PERFECT PH COPD: A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients with Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease

Grants and Contracts Details

StatusActive
Effective start/end date1/21/2210/9/23

Funding

  • Lung Biotechnology PBC: $2.00